• 8603 Citations
  • 37 h-Index
1987 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Outputs

2016

Differences in the patterns of anti-pd1 (PD1) toxicity between tumor streams

Sabanathan, D., Kong, B., Byrne, N., Wegener, V., Eslick, G., Nagrial, A., Hui, R., Kefford, R., Gurney, H. & Carlino, M. S., 2016, In : Asia-Pacific Journal of Clinical Oncology. 12, Suppl. S4, p. 68-68 1 p.

Research output: Contribution to journalMeeting abstract

Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study

Fox, P., Balleine, R. L., Lee, C., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wong, M., Wilcken, N. & Gurney, H., 1 Jul 2016, In : Clinical Cancer Research. 22, 13, p. 3164-3171 8 p.

Research output: Contribution to journalArticle

29 Citations (Scopus)

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

Nath, C. E., Trotman, J., Tiley, C., Presgrave, P., Joshua, D., Kerridge, I., Kwan, Y. L., Gurney, H., McLachlan, A. J., Earl, J. W., Nivison-Smith, I., Zeng, L. & Shaw, P. J., Jul 2016, In : British Journal of Clinical Pharmacology. 82, 1, p. 149-159 11 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Lawrence, N., Martin, A., Toner, G., Stockler, M., Buizen, L., Thomson, D., Gebski, V., Friedlander, M., Yeung, A., Wong, N., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S., Lewis, C., Vasey, P. & Grimison, P., 1 Dec 2016, In : Annals of oncology : official journal of the European Society for Medical Oncology. 27, 12, p. 2302-2303 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

MILGa-01-a first in human study assessing the safety and tolerability of chMIL-38 in prostate cancer

Sabanathan, D., Gurney, H., Gillatt, D., Trifunovic, M., Magnussen, J., Poursoltan, P., Shon, K. H. O., Walsh, B. J., Mazure, H., Velonas, V., Thurecht, K., Quach Truong, Wissmueller, S. & Campbell, D., Aug 2016, In : BJU international. 118, Suppl. 1, p. 14-15 2 p.

Research output: Contribution to journalMeeting abstract

Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011

van Leeuwen, M. T., Gurney, H., Turner, J. J., Turner, S. L., Pearson, S. A., Laaksonen, M. A., Harnett, P., Balakrishnar, B., Sabanathan, D. & Vajdic, C. M., 1 Aug 2016, In : Cancer Epidemiology. 43, p. 15-21 7 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Real-world experience of the feasibility and tolerability of the 2:1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia

Crumbaker, M., Gurney, H., Guminski, A., Wong, S., Sabanathan, D. & Pavlakis, N., Jul 2016, In : Asia-Pacific Journal of Clinical Oncology. 12, S3, p. 47 1 p., abs#209.

Research output: Contribution to journalMeeting abstract

Tactic: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer

Ferraro, D., Goldstein, D., O’Connell, R. L., Zalcberg, J. R., Sjoquist, K. M., Tebbutt, N. C., Grimison, P., McLachlan, S., Lipton, L. L., Vasey, P., Gebski, V. J., Aiken, C., Cronk, M., Ng, S., Karapetis, C. S., Shannon, J., Shannon, J., Tebbutt, N., Ng, S., Cronk, M. & 48 others, Karapetis, C., Sjoquist, K., Aiken, C., Do, V., Marschner, I., Friedlander, M., Gurney, H., Simes, J., Hague, W., O’Connell, R., Gebski, V., Aiken, C., Gorzeman, M., Pike, R., Miranda, K., Waring, P., Ferraro, D., Lau, D., Fox, S., Tebbutt, N., Liu, Y., Vasey, P., Wood, T., Cronk, M., Cocks, C., Simmons, K., Shannon, J., McCourt, J., Jefford, M., Hobinchet, A., Grimison, P., Mirco, B., Sagong, J., Ng, S., Dudukovic, S., Aghmesheh, M., Parker, S., Segelov, E., Ratnayake, L., McLachlan, S., Ranieri, N., Varma, S., Page, J., Heyer, E., Abdi, E., Chorlton, C., Lipton, L. & Wilkinson, L., 1 Aug 2016, In : Cancer Chemotherapy and Pharmacology. 78, 2, p. 361-367 7 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Tamoxifen, CYP2D6 and endoxifen in the treatment of hormone sensitive breast cancer: demystifying the connections

Lee, C. I. & Gurney, H., 1 Nov 2016, In : Cancer Forum. 40, 3, p. 4-10 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

The effect of pulmonary function testing on bleomycin dosing in germ cell tumours

Roncolato, F. T., Chatfield, M., Houghton, B., Toner, G., Stockler, M., Thomson, D., Friedlander, M., Gurney, H., Rosenthal, M., Grimison, P. & The Australian and New Zealand Urogenital Prostate Cancer Trials Group (ANZUP), 1 Aug 2016, In : Internal Medicine Journal. 46, 8, p. 893-898 6 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study

Smith, A. B., Butow, P., Olver, I., Luckett, T., Grimison, P., Toner, G. C., Stockler, M. R., Hovey, E., Stubbs, J., Turner, S., Hruby, G., Gurney, H., Alam, M., Cox, K. & King, M. T., 1 Apr 2016, In : Journal of Cancer Survivorship. 10, 2, p. 223-233 11 p.

Research output: Contribution to journalArticle

31 Citations (Scopus)
2015

CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)

Motzer, R. J., Escudier, B., Mcdermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Xu, L-A., Waxman, I. M., Sharma, P. & 1 others, CheckMate 025 Investigators, Dec 2015, In : BJU international. 116, S5, p. 17 1 p.

Research output: Contribution to journalMeeting abstract

12 Citations (Scopus)

CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)

Sharma, P., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Xu, L. A., Waxman, I. M. & Motzer, R. J., Sep 2015, In : European Journal of Cancer. 51, Supplement 3, p. S708 1 p.

Research output: Contribution to journalMeeting abstract

Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia

Parente, P., Gurney, H., Ng, S. & Bahre, M., 1 Sep 2015, In : Asia-Pacific Journal of Clinical Oncology. 11, 3, p. 199-207 9 p.

Research output: Contribution to journalReview article

3 Citations (Scopus)

Describing patterns of care in pancreatic cancer a population-based study: a population-based study

Burmeister, E. A., OʼConnell, D. L., Beesley, V. L., Goldstein, D., Gooden, H. M., Janda, M., Jordan, S. J., Merrett, N. D., Payne, M. E., Wyld, D. K., Neale, R. E. & Pancreatic Cancer Patterns of Care Study Group, Nov 2015, In : Pancreas. 44, 8, p. 1259-65 7 p.

Research output: Contribution to journalArticle

26 Citations (Scopus)

Doctor-patient communication: a study of Australian ethnic urological cancer patients

Cerimagic, S., Ahmadi, N., Gurney, H. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 82-91 10 p.

Research output: Contribution to journalArticle

Nivolumab versus everolimus in advanced renal-cell carcinoma

Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Choueiri, T. K., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Tomita, Y., Schutz, F. A. & 8 others, Kollmannsberger, C., Larkin, J., Ravaud, A., Simon, J. S., Xu, L. A., Waxman, I. M., Sharma, P. & CheckMate 025 Investigators, 5 Nov 2015, In : New England Journal of Medicine. 373, 19, p. 1803-1813 11 p.

Research output: Contribution to journalArticle

2531 Citations (Scopus)

Positive lifestyle changes following urological cancer diagnoses: an Australian interview based study

Cerimagic, S., Ahmadi, N., Gurney, H., Hossack, T. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 110-119 10 p.

Research output: Contribution to journalArticle

2014

Accelerated BEP for metastatic germ cell tumours: A multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Grimison, P. S., Stockler, M. R., Chatfield, M., Thomson, D. B., Gebski, V., Friedlander, M., Boland, A. L., Houghton, B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. & Toner, G. C., 2014, In : Annals of Oncology. 25, 1, p. 143-148 6 p., mdt369.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662

Diekstra, M. H. M., Klümpen, H. J., Lolkema, M. P. J. K., Yu, H., Kloth, J. S. L., Gelderblom, H., Van Schaik, R. H. N., Gurney, H., Swen, J. J., Huitema, A. D. R., Steeghs, N. & Mathijssen, R. H. J., 2014, In : Clinical Pharmacology and Therapeutics. 96, 1, p. 81-89 9 p.

Research output: Contribution to journalArticle

51 Citations (Scopus)

Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer

Parente, P., Parnis, F. & Gurney, H., 2014, In : Asia-Pacific Journal of Clinical Oncology. 10, 3, p. 205-215 11 p.

Research output: Contribution to journalReview article

6 Citations (Scopus)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

Lin, H. M., Castillo, L., Mahon, K. L., Chiam, K., Lee, B. Y., Nguyen, Q., Boyer, M. J., Stockler, M. R., Pavlakis, N., Marx, G., Mallesara, G., Gurney, H., Clark, S. J., Swarbrick, A., Daly, R. J. & Horvath, L. G., 13 May 2014, In : British Journal of Cancer. 110, 10, p. 2462-2471 10 p.

Research output: Contribution to journalArticle

80 Citations (Scopus)

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

Mahon, K. L., Qu, W., Devaney, J., Paul, C., Castillo, L., Wykes, R. J., Chatfield, M. D., Boyer, M. J., Stockler, M. R., Marx, G., Gurney, H., Mallesara, G., Molloy, P. L., Horvath, L. G. & Clark, S. J., 28 Oct 2014, In : British Journal of Cancer. 111, 9, p. 1802-1809 8 p.

Research output: Contribution to journalArticle

Open Access
File
41 Citations (Scopus)
3 Downloads (Pure)

Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: The ClearSun study

Kloth, J. S. L., Klümpen, H. J., Yu, H., Eechoute, K., Samer, C. F., Kam, B. L. R., Huitema, A. D. R., Daali, Y., Zwinderman, A. H., Balakrishnar, B., Bennink, R. J., Wong, M., Schellens, J. H. M., Mathijssen, R. H. J. & Gurney, H., Mar 2014, In : Clinical Pharmacokinetics. 53, 3, p. 261-269 9 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Racial disparity in metastatic renal cell cancer: The pharmaco-anthropology of sunitinib

Zhang, A. & Gurney, H., 2014, In : Asia-Pacific Journal of Clinical Oncology. 10, 3, p. 197-199 3 p.

Research output: Contribution to journalEditorial

Use of targeted therapies for advanced renal cell carcinoma in the asia-pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia

Ye, D., Eto, M., Chung, J. S., Kimura, G., Chang, W. C., Chang, Y. H., Pang, S. T., Lee, J. L., Niu, Y., Gurney, H. & Uemura, H., 2014, In : Clinical Genitourinary Cancer. 12, 4, p. 225-233 9 p.

Research output: Contribution to journalReview article

14 Citations (Scopus)
2013

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L. & Gurney, H., 20 May 2013, In : Journal of Clinical Oncology. 31, 15 supplement, p. 1-1 1 p., 543.

Research output: Contribution to journalMeeting abstract

19 Citations (Scopus)

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L. & Gurney, H., 1 Jul 2013, In : Asia-Pacific Journal of Clinical Oncology. 9, Supplement 2, p. 45-45 1 p.

Research output: Contribution to journalMeeting abstract

Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2

Zhou, F., Zheng, J., Zhu, L., Jodal, A., Cui, P. H., Wong, M., Gurney, H., Church, W. B. & Murray, M., 2013, In : AAPS Journal. 15, 4, p. 1099-1108 10 p.

Research output: Contribution to journalArticle

28 Citations (Scopus)

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H. & Donskov, F., 2013, In : Journal of Translational Medicine. 11, p. 189 1 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)

Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer

Won, A. C. M., Gurney, H., Marx, G., De Souza, P. & Patel, M. I., Aug 2013, In : BJU international. 112, 4, p. E250-E255 6 p.

Research output: Contribution to journalArticle

65 Citations (Scopus)

The prevalence and correlates of supportive care needs in testicular cancer survivors: A cross-sectional study

Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G. C., Stockler, M., Hovey, E., Stubbs, J., Hruby, G., Gurney, H., Turner, S., Alam, M., Cox, K. & Olver, I., Nov 2013, In : Psycho-Oncology. 22, 11, p. 2557-2564 8 p.

Research output: Contribution to journalArticle

34 Citations (Scopus)
2012

Accelerated BEP for metastatic germ cell tumors: combined analysis of Australian and UK phase I/II trials

Grimison, P. S., Chatfield, M. D., Mazhar, D., Toner, G. C., Chester, J. D., Stockler, M. R., Stark, D. P., Thomson, D. B., Shamash, J., Friedlander, M., White, J., Gebski, V., Wason, J., Boland, A. L., Rimmer, Y. L., McDonald, A., Gurney, H., Rosenthal, M., Singhal, N., Williams, M. V. & 2 others, Australian New Zealand Urogenital & West Anglia Cancer Research Network, 20 May 2012, In : Journal of Clinical Oncology. 30, 15 supplement, p. 4531-4531 1 p.

Research output: Contribution to journalMeeting abstract

Concomitant CYP2D6 inhibitor use and plasma metabolite levels in breast cancer patients treated with tamoxifen

Fox, P., Balakrishnar, B., Menzies, A., Liddle, C., Coulter, S., Provan, P., Gebski, V., Hui, R., Kefford, R., Wilcken, N., Balleine, R. & Gurney, H., 31 Jul 2012, In : Asia-Pacific Journal of Clinical Oncology. 8, Supplement 2, p. 52-52 1 p.

Research output: Contribution to journalMeeting abstract

CYP2D6 genotype and adverse effects as indicators of plasma endoxifen in breast cancer patients taking tamoxifen

Balakrishnar, B., Menzies, A. M., Ali, S. S., Yeap, S. H., Gao, B., Liddle, C., Coulter, S., Provan, P., Gebski, V., Hui, R., Kefford, R., Wilcken, N., Balleine, R. L. & Gurney, H., 20 May 2012, In : Journal of Clinical Oncology. 30, Supplement 15, p. 550-550 1 p.

Research output: Contribution to journalMeeting abstract

Evidence for therapeutic drug monitoring of targeted anticancer therapies

Gao, B., Yeap, S., Clements, A., Balakrishnar, B., Wong, M. & Gurney, H., 10 Nov 2012, In : Journal of Clinical Oncology. 30, 32, p. 4017-4025 9 p.

Research output: Contribution to journalReview article

121 Citations (Scopus)
2011

Accelerated BEP for advanced germ cell tumors: an Australian multicenter phase I/II trial.

Grimison, P. S., Thomson, D. B., Stockler, M. R., Chatfield, M. D., Friedlander, M., Gebski, V., Boland, A. L., Houghton, B. B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A., Toner, G. C. & Australian New Zealand Urogenital, 20 May 2011, In : Journal of Clinical Oncology. 29, 15 supplement, p. 4561-4561 1 p.

Research output: Contribution to journalMeeting abstract

49 Citations (Scopus)

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

Lee, C. K., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Reed, N., Gebski, V., Pujade-Lauraine, E., Lord, S., Simes, R. J. & Friedlander, M., 26 Jul 2011, In : British Journal of Cancer. 105, 3, p. 360-365 6 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Environmental and genetic factors affecting transport of imatinib by OATP1A2

Eechoute, K., Franke, R. M., Loos, W. J., Scherkenbach, L. A., Boere, I., Verweij, J., Gurney, H., Kim, R. B., Tirona, R. G., Mathijssen, R. H. J. & Sparreboom, A., 2011, In : Clinical Pharmacology and Therapeutics. 89, 6, p. 816-820 5 p.

Research output: Contribution to journalArticle

40 Citations (Scopus)

Metformin in prostate cancer: Two for the price of one

Clements, A., Gao, B., Yeap, S. H. O., Wong, M. K. Y., Ali, S. S. & Gurney, H., Dec 2011, In : Annals of Oncology. 22, 12, p. 2556-2560 5 p., mdr037.

Research output: Contribution to journalReview article

46 Citations (Scopus)

Moving towards dose individualization of tyrosine kinase inhibitors

Klümpen, H. J., Samer, C. F., Mathijssen, R. H. J., Schellens, J. H. M. & Gurney, H., Jun 2011, In : Cancer Treatment Reviews. 37, 4, p. 251-260 10 p.

Research output: Contribution to journalReview article

69 Citations (Scopus)

Paraneoplastic hepatic dysfunction in metastatic prostate cancer: the role of cytokine dysregulation

Nguyen, V., Gurney, H. & Van Der Poorten, D., 10 Jan 2011, In : Journal of Clinical Oncology. 29, 2, p. 1-3 3 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

The effect of pulmonary function testing on bleomycin dosing in germ cell tumors

Houghton, B. B., Grimison, P. S., Toner, G. C., Chatfield, M., Thomson, D. B., Friedlander, M., Gebski, V., Rosenthal, M., Gurney, H. & Stockler, M., 1 Mar 2011, In : Journal of Clinical Oncology. 29, 7 supplement, p. 227-227 1 p.

Research output: Contribution to journalMeeting abstract

2010

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: Updated analysis of a randomized trial

Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gebski, V. J., Lewis, C. R., Levi, J. A., Boyer, M. J., Gurney, H., Craft, P., Boland, A. L., Simes, R. J. & Toner, G. C., 18 Aug 2010, In : Journal of the National Cancer Institute. 102, 16, p. 1253-1262 10 p.

Research output: Contribution to journalArticle

44 Citations (Scopus)

Inhibitors of mTOR

Klümpen, H. J., Beijnen, J. H., Gurney, H. & Schellens, J. H. M., Dec 2010, In : Oncologist. 15, 12, p. 1262-1269 8 p.

Research output: Contribution to journalReview article

43 Citations (Scopus)

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

Nath, C. E., Shaw, P. J., Trotman, J., Zeng, L., Duffull, S. B., Hegarty, G., McLachlan, A. J., Gurney, H., Kerridge, I., Kwan, Y. L., Presgrave, P., Tiley, C., Joshua, D. & Earl, J., May 2010, In : British Journal of Clinical Pharmacology. 69, 5, p. 484-497 14 p.

Research output: Contribution to journalArticle

43 Citations (Scopus)
2009

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer

Pezaro, C., Rosenthal, M. A., Gurney, H., Davis, I. D., Underhill, C., Boyer, M. J., Kotasek, D., Solomon, B. & Toner, G. C., Aug 2009, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 32, 4, p. 338-341 4 p.

Research output: Contribution to journalArticle

39 Citations (Scopus)

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: updated analysis of a randomized trial with 8 years follow-up

Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gurney, H., Lewis, C. R., Gebski, V. J., Boland, A. L., Toner, G. C. & Australia New Zealand Germ Cell, 20 May 2009, In : Journal of Clinical Oncology. 27, 15, p. 5016-5016 2 p.

Research output: Contribution to journalMeeting abstract

Irinogenetics: How many stars are there in the sky?

Mathijssen, R. H. J. & Gurney, H., 1 Jun 2009, In : Journal of Clinical Oncology. 27, 16, p. 2578-2579 2 p.

Research output: Contribution to journalEditorial

11 Citations (Scopus)